Islam Mohammad Redwanul, Moinuddin Md, Ahmed Ayeda, Rahman Syed Moshfiqur
International Maternal and Child Health (IMCH), Department of Women's and Children's Health, Uppsala University, MTC-huset, Dag Hammarskjölds väg 14B, SE-75237, Uppsala, Sweden.
Institute of Child Health, University College London, 30 Guildford Street, London, WC1N 1EH, UK.
BMC Med. 2021 Jan 15;19(1):5. doi: 10.1186/s12916-020-01879-1.
Malnutrition continues to affect under-five children in Africa to an overwhelming proportion. The situation is further compounded by the burden of sickle cell disease (SCD). However, association of SCD with stunting, wasting, and underweight in a nationally representative sample of under-five children remains unexplored. We aimed to describe prevalence of undernutrition by sickle cell status, to evaluate its association with growth faltering ascertained by anthropometric indices, and to explore mediating role of hemoglobin.
We availed data from the 2018 Nigeria Demographic and Health Survey (DHS) and the sample comprised 11,233 children aged 6-59 months who were successfully genotyped for SCD. The DHS employed a two-stage, stratified sampling strategy. SickleSCAN rapid diagnostic test was used for SCD genotyping. Z-scores of length/height-for-age (HAZ), weight-for-height (WHZ), and weight-for-age (WAZ) were computed against the 2006 World Health Organization Child Growth Standards. We fitted logistic regression models to evaluate association of SCD with stunting, wasting, and underweight. Mediation analysis was performed to capture the indirect effect of and proportion of total effect mediated through hemoglobin level in SCD-anthropometric indices association.
Prevalences of stunting, wasting, and underweight among children with SCD were 55.4% (54.5-56.4), 9.1% (8.6-9.7), and 38.9% (38.0-39.8), respectively. The odds of stunting were 2.39 times higher (adjusted odds ratio (aOR) 2.39, 95% CI: 1.26-4.54) among sickle children than those with normal hemoglobin. SCD was also significantly associated with underweight (aOR 2.64, 95% CI: 1.25-5.98), but not with wasting (aOR: 1.60, 95% CI 0.85-3.02). Association of SCD with all three anthropometric indices was significantly mediated through hemoglobin level: for SCD-HAZ, the adjusted indirect effect (aIE) was - 0.328 (95% CI: - 0.387, - 0.270); for SCD-WHZ, the aIE was - 0.080 (95% CI: - 0.114, - 0.050); and for SCD-WAZ, the aIE was - 0.245 (95% CI: - 0.291, - 0.200).
We presented compelling evidence of the negative impact of SCD on anthropometric indices of nutritional status of under-five children. Integration of a nutrition-oriented approach into a definitive SCD care package and its nationwide implementation could bring promising results by mitigating the nutritional vulnerability of children with SCD.
营养不良仍然严重影响着非洲五岁以下儿童。镰状细胞病(SCD)的负担进一步加剧了这种情况。然而,在全国具有代表性的五岁以下儿童样本中,SCD与发育迟缓、消瘦和体重不足之间的关联仍未得到探索。我们旨在描述不同镰状细胞状态下的营养不良患病率,评估其与通过人体测量指标确定的生长发育迟缓的关联,并探讨血红蛋白的中介作用。
我们利用了2018年尼日利亚人口与健康调查(DHS)的数据,样本包括11233名年龄在6至59个月的儿童,他们成功进行了SCD基因分型。DHS采用了两阶段分层抽样策略。使用SickleSCAN快速诊断测试进行SCD基因分型。根据2006年世界卫生组织儿童生长标准计算年龄别身长/身高(HAZ)、身高别体重(WHZ)和年龄别体重(WAZ)的Z评分。我们拟合逻辑回归模型来评估SCD与发育迟缓、消瘦和体重不足的关联。进行中介分析以捕捉SCD与人体测量指标关联中通过血红蛋白水平介导的间接效应和总效应的比例。
SCD患儿中发育迟缓、消瘦和体重不足的患病率分别为55.4%(54.5 - 56.4)、9.1%(8.6 - 9.7)和38.9%(38.0 - 39.8)。镰状细胞患儿发育迟缓的几率比血红蛋白正常的患儿高2.39倍(调整后的优势比(aOR)为2.39,95%置信区间:1.26 - 4.54)。SCD也与体重不足显著相关(aOR 2.64,95%置信区间:1.25 - 5.98),但与消瘦无关(aOR:1.60,95%置信区间0.85 - 3.02)。SCD与所有三个人体测量指标的关联均通过血红蛋白水平显著介导:对于SCD - HAZ,调整后的间接效应(aIE)为 - 0.328(95%置信区间: - 0.387, - 0.270);对于SCD - WHZ,aIE为 - 0.080(95%置信区间: - 0.114, - 0.050);对于SCD - WAZ,aIE为 - 0.245(95%置信区间: - 0.291, - 0.200)。
我们提供了令人信服的证据,证明SCD对五岁以下儿童营养状况的人体测量指标有负面影响。将以营养为导向的方法纳入确定性的SCD护理方案并在全国范围内实施,可能通过减轻SCD患儿的营养脆弱性带来有希望的结果。